Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy

AIMS: Beta-blockers reduce morbidity and mortality in chronic heart failure (HF) patients with reduced ejection fraction. However, there is heterogeneity in the response to these drugs, perhaps due to genetic variations in the β1-adrenergic receptor (ADRβ1). We examined whether the Arg389Gly polymor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fiuzat, Mona, Neely, Megan L., Starr, Aijing Z., Kraus, William E., Felker, G. Michael, Donahue, Mark, Adams, Kirkwood, Piña, Ileana L., Whellan, David, O'Connor, Christopher M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2013
Gaiak:
Genetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3707429/
https://ncbi.nlm.nih.gov/pubmed/23115322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hfs175
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak